Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine sulfate sodium chloride is a stabilized salt form of the amino sugar glucosamine, which serves as a fundamental building block for the biochemical synthesis of glycosylated proteins and lipids. It is primarily utilized in the management of osteoarthritis, particularly of the knee, where it acts as a precursor for the synthesis of cartilage matrix components such as proteoglycans and glycosaminoglycans. Beyond its role as a substrate for cartilage repair, the drug exhibits anti-inflammatory properties by inhibiting the interleukin-1 beta (IL-1β) signaling pathway, thereby reducing the expression of inflammatory mediators like cyclooxygenase-2 (COX-2) and prostaglandin E2. While widely available as a dietary supplement in the United States, it is regulated as a prescription pharmaceutical in many European and Asian jurisdictions, with the crystalline formulation developed by Rottapharm being the most extensively studied clinical version.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate sodium chloride.